Clinical Trials in Philadelphia

Showing 11641-11660 of 17,926 trials

A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache

NCT02991430

This study will assess the efficacy of a neuromodulation device for the treatment of episodic migraine headache.

Scion NeuroStim45 participantsStarted Jun 2017

Scottsdale, Arizona, United States • West Palm Beach, Florida, United States • Chicago, Illinois, United States +7 more locations

COMPLETEDPhase 2< 1 mile

A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)

NCT02559570

The purpose of this study was to evaluate dose response of the safety and efficacy of linaclotide for the treatment of functional constipation (FC), in children age 6-17 years. This study includes up to a 4-week Screening Period, and a 2 to 3-week Pretreatment Period. Participants age 6-11 years will receive oral liquid formulation and participants 12-17 years will receive solid oral capsule or liquid oral solution. Children ages 6-11 years meeting the entry criteria will be randomized to 1 of 3 doses of linaclotide or placebo for 4 weeks. Children ages 12-17 years meeting the entry criteria will be randomized to 1 of 4 doses of linaclotide or placebo for 4 weeks. This 4-week study will assess the effects of linaclotide on bowel movement frequency, as well as other bowel symptoms of FC.

Functional Constipation in Children Ages 6-17 Years

Forest Laboratories173 participantsStarted Nov 2015

Hot Springs, Arkansas, United States • Little Rock, Arkansas, United States • Anaheim, California, United States +59 more locations

A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache

A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)

Find Trials by Condition in Philadelphia

Sedation Strategy and Cognitive Outcome After Critical Illness in Early Childhood

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM

A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)

Assessing Superion Clinical Endpoints vs. Decompression

Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes

Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder

PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy

Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age

A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency

Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Balancing Risk: Red Blood Cell Transfusion Strategies In Cardiac Surgery

REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)

Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2

Clinical Evaluation of Visco-Assisted CyPass® Micro-Stent Implantation in Patients With Open Angle Glaucoma